ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 2456

$847K Total Retail Price of All Prescriptions

Rank: 69 out of 2456

652 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 652 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 652 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 562 498 1 2
LISINOPRIL 490 440 2 1
OMEPRAZOLE 456 349 3 3
AMLODIPINE BESYLATE 411 355 4 5
LEVOTHYROXINE SODIUM 293 268 5 4
METFORMIN HCL ER 283 225 6 59
FUROSEMIDE 276 215 7 8
HYDROCHLOROTHIAZIDE 229 212 8 7
WARFARIN SODIUM 226 192 9 9
ATORVASTATIN CALCIUM 218 182 10 12
ATENOLOL 213 173 11 6
PREDNISONE 195 145 12 39
HYDROCODONE-ACETAMINOPHEN 192 121 S3 13 20
TAMSULOSIN HCL 184 170 14 32
METOPROLOL SUCCINATE 180 167 15 13
METOPROLOL TARTRATE 175 166 16 10
SERTRALINE HCL 167 148 17 21
CITALOPRAM HBR 164 131 18 14
JANUVIA 162 133 19 81
FLUOXETINE HCL 138 100 20 45
ISOSORBIDE MONONITRATE ER 135 116 21 48
TRAMADOL HCL 135 103 21 24
ALLOPURINOL 134 115 23 27
PANTOPRAZOLE SODIUM 133 95 24 37
ZOLPIDEM TARTRATE 132 99 25 28
FLUTICASONE PROPIONATE 131 101 26 30
OXYCODONE HCL 130 32 S2 27 38
SPIRIVA 128 95 28 43
LOSARTAN POTASSIUM 127 120 29 18
NAMENDA 123 123 30 42
KLOR-CON M20 119 79 31 69
CRESTOR 116 107 32 25
PROAIR HFA 115 45 33 22
OXYCODONE-ACETAMINOPHEN 114 43 S2 34 35
GABAPENTIN 110 52 35 16
ZETIA 108 108 36 86
DIGOXIN 107 107 37 49
PRAVASTATIN SODIUM 104 81 38 15
METFORMIN HCL 101 78 39 11
CLOPIDOGREL 98 83 40 55
TRAZODONE HCL 95 56 41 17
OXYCONTIN 92 47 S2 42 129
FINASTERIDE 89 71 43 66
METHADONE HCL 89 0 S2 43 135
CYMBALTA 77 53 45 65
PLAVIX 77 70 45 79
AMITRIPTYLINE HCL 70 52 R 47 83
ADVAIR DISKUS 67 48 48 36
CLONIDINE HCL 64 60 49 111
VENLAFAXINE HCL ER 61 20 50 92
POTASSIUM CHLORIDE 60 52 51 33
SYNTHROID 59 59 52 118
BUPROPION XL 58 33 53 271
ABILIFY 58 37 53 95
CIPROFLOXACIN HCL 56 53 55 87
LIPITOR 56 48 55 63
ALENDRONATE SODIUM 52 39 57 19
NORTRIPTYLINE HCL 52 33 57 227
FENTANYL 52 29 S2 57 115
PAROXETINE HCL 50 46 60 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.